![](/img/cover-not-exists.png)
EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients: how do we interpret the clinical and biomarker data?
Raffaele Califano, Fiona H. Blackhall, Giovanna Finocchiaro, Luca Toschi, Nicholas Thatcher, Federico Cappuzzo, Lucio CrinòVolume:
3
Language:
english
Pages:
14
DOI:
10.1007/s11523-008-0084-7
Date:
July, 2008
File:
PDF, 253 KB
english, 2008